For many patients peritoneal dialysis (PD) is the preferred form of dialysis to treat kidney disease as it provides greater flexibility and the ability to dialyse at home. However, PD use in Australia has been decreasing over the last 10 years. A big reason for this drop is the risk of infection. The best way to prevent PD related infections is to make sure that patients have good training in PD techniques. The researchers of this study have developed TEACH-PD, a new education package for training both PD nurses and PD patients. The aim of this study is to find out whether TEACH-PD training reduces the number of PD related infections.
End stage kidney disease is fatal unless treated with dialysis or transplant. Peritoneal dialysis (PD) is a core dialysis modality offering home-based care for patients. PD utilization is frequently threatened beyond 5 years for most patients due to PD-related infections. Patient training is a critical cornerstone of mitigating infection risk and maximizing PD durability (technique survival), but training practices are characterized by a lack of standardization and severe heterogeneity. There is no high-level evidence to inform PD training. Accordingly, a structured program encompassing how and what to teach PD patients at the inception of PD treatment has the potential to reduce serious PD-related infections, extend the longevity of PD, support cost-effective home-based dialysis care, and reduce costs and health service utilization associated with hospitalization and transition to haemodialysis. TEACH-PD is a standardised modular curriculum for both PD nurse trainers and patients that has been collaboratively developed by renal nurses, doctors, educationalists and patients, aligned to current International Society for Peritoneal Dialysis (ISPD) guidelines, utilizing modern adult learning principles. The TEACH-PD program is feasible and acceptable, as demonstrated in a successful pilot study. The primary objective of TEACH-PD CRCT (Targeted Education ApproaCH to improve Peritoneal Dialysis outcomes - a Cluster Randomised Controlled Trial) is to determine whether implementation of standardised training modules based on ISPD guidelines targeting both PD trainers and patients results in a longer time to the composite end-point of exit site infections, tunnel infections and peritonitis in incident PD patients compared to existing training practices. TEACH-PD is a registry-based, pragmatic, multi-center, multinational trial, randomising PD units to implementing TEACH-PD training modules targeted at PD trainers and incident PD patients versus standard existing practices. An estimated 1,500 patient new to PD will be recruited from at least approximately 42-44 PD units in Australia and New Zealand.The study is being coordinated by the University of Queensland (operating through the Australasian Kidney Trial Network). The TEACH-PD training modules have been developed by a core group of renal nurses from the HOME Network in conjunction with senior medical clinicians from the Australasian Kidney Trials Network, eLearning curriculum developers, consumer representatives, and education experts, in line with the ISPD guidelines, utilizing modern adult learning principles and best practice eLearning techniques. The modules will be implemented at PD units in Australia and New Zealand to formally evaluate whether, compared with standard care, a standardised training curriculum will reduce the rate of PD-related infections and improve technique survival, resulting in better outcomes for patients receiving PD and significant cost-savings to the community.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Enrollment
1,500
The TEACH-PD training modules have been developed by a core group of renal nurses from the HOME Network in conjunction with senior medical clinicians from the Australasian Kidney Trials Network, eLearning curriculum developers, consumer representatives, and education experts, in line with the International Society for Peritoneal Dialysis guidelines, utilizing modern adult learning principles and best practice eLearning techniques.
Current PD training materials and plan
Canberra Hospital
Canberra, Australian Capital Territory, Australia
St Vincent's Hospital Sydney
Darlinghurst, New South Wales, Australia
Gosford Hospital
Gosford, New South Wales, Australia
Lismore Hospital
Lismore, New South Wales, Australia
Orange Hospital
Orange, New South Wales, Australia
Time to the first occurrence of any PD-related infection
Time to the first occurrence of any PD-related infection including exit site infection, tunnel infection or peritonitis
Time frame: From the PD start date until first PD-related infection, assessed up to 4 years
Time to first exit site infection
Time to first exit site infection
Time frame: From the PD start date until first exit site infection, assessed up to 4 years
Time to first tunnel infection
Time to first tunnel infection
Time frame: From the PD start date until first tunnel infection, assessed up to 4 years
Time to first episode of peritonitis
Time to first episode of peritonitis
Time frame: From the PD start date until first peritonitis episode, assessed up to 4 years
Time to infection-associated catheter removal
Time to infection-associated catheter removal
Time frame: From the PD start date until first infection-associated catheter removal, assessed up to 4 years
Incidence of technique failure - 30 days
Incidence of technique failure defined as transfer to haemodialysis for greater than 30-days and/or death within this time
Time frame: Assessed at 30 days after transfer to HD or if death occurs within this period
Incidence of technique failure - 180 days
Incidence of technique failure defined as transfer to haemodialysis for greater than 180-days and/or death within this time
Time frame: Assessed at 180 days after transfer to HD or if death occurs within this period
Incidence of all-cause hospitalization
Incidence of all-cause hospitalization collected via health department hospitalization data linkage
Time frame: Assessed from the PD start date, over up to 4 years
Incidence of all-cause mortality
Incidence of all-cause mortality
Time frame: Assessed from the PD start date, over up to 4 years
Participant Quality of Life questionnaire
Participant-reported Quality of Life measured using EQ-5D-5L (EuroQol-5 dimensions questionnaire). EQ-5D-5L measures quality of life using 2 methods - a descriptive scale and a Visual Analogue Scale. The descriptive scale comprises 5 dimensions (mobility, self care, usual activities, pain/discomfort, anxiety/ depression). Each dimension has 5 measurement levels: no problems (1), slight problems (2), moderate problems (3), severe problems (4), and extreme problems (5). Numbers associated with levels can be used to report an index score. The VAS records the respondent's self-rated health on a 20 cm vertical, visual analogue scale with endpoints labelled 'the best health you can imagine' (100) and 'the worst health you can imagine' (0).
Time frame: Completed at baseline, 6, 12, 18 and 24 months
Health-care cost-effectiveness analysis
Difference in the incremental cost per Quality Adjusted Life Years gained between treatment arms
Time frame: Assessed from the PD start date, over up to 4 years
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Royal North Shore Hospital
St Leonards, New South Wales, Australia
Liverpool Hospital
Sydney, New South Wales, Australia
Nepean/Blacktown Hospital
Sydney, New South Wales, Australia
Prince of Wales Hospital
Sydney, New South Wales, Australia
Royal Prince Alfred/Concord Hospital
Sydney, New South Wales, Australia
...and 38 more locations